Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. TRAVATAN (N/R/ travoprost)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

TRAVATAN (N/R/ travoprost)

Medicine - Posted on Feb 05 2018 - Updated on Jun 12 2019
Active substance (DCI)
  • travoprost
history (6)
  • 1/24/18

    TRAVATAN (travoprost)

    Maintien du remboursement dans les mêmes conditions.
    icône flèche
  • 10/5/16

    TRAVATAN (travoprost), glaucoma eye drops

    No clinical benefit demonstrated in paediatric patients, by comparison with its comparators, in the reduction of elevated in...
    CAV :
    54321
    icône flèche
  • 5/9/12

    TRAVATAN (travoprost)

    TRAVATAN (travoprost)
    icône flèche
  • 11/15/06

    TRAVATAN (travoprost)

    TRAVATAN (travoprost)
    icône flèche
  • 11/26/03

    TRAVATAN (travoprost)

    TRAVATAN (travoprost)
    CAV :
    54321
    icône flèche
  • 1/23/02

    TRAVATAN (travoprost)

    TRAVATAN (travoprost)
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • S01EE04
Manufacturer
ALCON SAS/ NOVARTIS PHARMA SAS/
Presentation

TRAVATAN 40 microgrammes/ml, collyre en solution (code CIS : 60670806)
1 flacon(s) polypropylène de 2,5 ml - (Code CIP : 34009 358 476 3 8)

All our publications
    Drug therapy Eye diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
FDtFFhMSqN6Qntum